Antiaging Quantum Living Inc.

AI-generated fair value estimate for this company.

Method: Revenue-multiple (EV/Sales) valuation: $1.47M TTM revenue x 1.5x justified sales multiple (comparable unprofitable micro-cap health/beauty and internet-retail companies typically trade at 1-2x sales given persistent net losses); no positive free cash flow exists so a DCF is not meaningful; 34.28M shares outstanding; no separately disclosed net cash/debt available to adjust equity value.

Reasoning: Company is pre-profitability with only $1.47M TTM revenue, a widening net loss (-$838k), and no disclosed positive operating cash flow, so a cash-flow DCF is unreliable; a conservative sales multiple benchmarked to comparable small unprofitable consumer/health-products microcaps is the most defensible proxy for fundamental value, and it implies a steep discount to the current speculative OTC market price of $0.58.